Core Insights - Dingdang Health's subsidiary, Dingdang Kuaiyao, has launched the innovative insomnia treatment drug, Leberesin (brand name: Daweike), which can be ordered online and delivered to patients' homes within 28 minutes, significantly improving accessibility and convenience for insomnia patients [1] - Leberesin is a non-psychoactive medication that aims to help long-term insomnia sufferers return to a natural sleep rhythm [1] - The drug has been approved in 26 countries and regions globally, with over 6 million users, and has recently received approval for domestic market entry [1] Company Strategy - Dingdang Health is focusing on the insomnia market and leveraging its digital capabilities through Dingdang Smart Pharmacy, which offers real-time online health consultation services, 24-hour professional medication delivery, AI medication reminders, and sleep health management guidance [1] - The company is committed to the "Innovative Drugs · Life Ark" initiative starting in 2025, having developed a portfolio of innovative drug products covering various disease areas, including insomnia, neurological disorders, endocrine metabolism, tumors, cardiovascular diseases, and inflammatory bowel disease [1]
叮当健康(09886.HK)上架莱博雷生 助力长期失眠患者回归自然睡眠